Cancers | Free Full-Text | A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First-
Leprosy Reactivation and Lepromatous Gangrene Associated with Chemotherapy for Advanced Gastric Cancer: A Case Report and Review of the Literature - | Semantic Scholar
PDF) REVIEW Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy
PDF) Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
Lung Cancer in Greece - Journal of Thoracic Oncology
Vol 4, No 14 (July 2016) - Annals of Translational Medicine
PDF) Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton
Table of Contents page: Journal of Thoracic Oncology
Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer - Urology
PDF) Current and Emerging Roles of Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small Cell Lung Cancer
Table of Contents page: Journal of Thoracic Oncology
PDF) Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer | Christos Alamanis and Christos Papadimitriou - Academia.edu
PDF) Bevacizumab in Ovarian Cancer
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink
PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy
PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative
PDF) 144PCyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab
World Journal of Surgical Oncology Reviewer Acknowledgement 2013 – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
PDF) Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature
PDF) Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by
Table of Contents page: Journal of Thoracic Oncology
PDF) Recent advances in diagnostic technologies in lung cancer
